In COVID-19 patients, AhR stimulation upregulates expression of mucins in alveolar epithelial cells, causing accumulation of alveolar mucus and leading to silent hypoxia formation, a unique feature of the disease (38). This evidence concerns the gene AHR and COVID-19.